• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用 FibroTouch 与 Fibroscan 检测慢性肝病患者的衰减参数与肝硬度值。

Attenuation parameter and liver stiffness measurement using FibroTouch vs Fibroscan in patients with chronic liver disease.

机构信息

Faculty of Medicine, Department of Medicine, Gastroenterology and Hepatology Unit, University of Malaya, Kuala Lumpur, Malaysia.

Department of Nursing Science, University of Malaya, Kuala Lumpur, Malaysia.

出版信息

PLoS One. 2021 May 3;16(5):e0250300. doi: 10.1371/journal.pone.0250300. eCollection 2021.

DOI:10.1371/journal.pone.0250300
PMID:33939744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8092664/
Abstract

BACKGROUND & AIM: We studied FibroTouch (FT) and Fibroscan (FS) examination results and their repeatability when performed by healthcare personnel of different background.

METHODS

FT and FS examinations were performed on patients with chronic liver disease by two operators, a doctor and a nurse, twice on each patient, at two different time points, independent of each other.

RESULTS

The data for 163 patients with 1304 examinations was analyzed. There was strong correlation between FT and FS for attenuation parameter (Spearman's rho 0.76, p<0.001) and liver stiffness measurement (LSM) (Spearman's rho 0.70, p<0.001). However, FT produced higher value at lower attenuation parameter and LSM, and lower value at higher attenuation parameter and LSM. There was substantial agreement when using 15kPa LSM cut-off, but only moderate agreement when using 10kPa and 20kPa LSM cut-offs and 248dB/m, 268dB/m and 280dB/m attenuation parameter cut-offs. The IQR for attenuation parameter and IQR/median for LSM were significantly lower for FT compared with FS (4dB/m vs 27dB/m, p<0.001, and 10 vs 12, p<0.001, respectively). The intra- and inter-observer reliability of attenuation parameter and LSM using FT and FS were good to excellent with intraclass correlation coefficients 0.89-0.99. FT had shorter examination time (33s vs 47s, p<0.001) and less invalid measurements (0 vs 2, p<0.001).

CONCLUSION

Measurements obtained with FT and FS strongly correlated, but significant differences in their absolute values, consistency, examination time and number of invalid measurements were observed. Either device can be used by healthcare personnel of different backgrounds when sufficiently trained.

摘要

背景与目的

我们研究了 FibroTouch(FT)和 Fibroscan(FS)检查结果及其在不同背景的医护人员进行检查时的可重复性。

方法

由两名操作员(一名医生和一名护士)对慢性肝病患者进行 FT 和 FS 检查,每位患者两次,在两个不同的时间点独立进行。

结果

对 163 名患者的 1304 次检查数据进行了分析。衰减参数(Spearman 相关系数 0.76,p<0.001)和肝硬度测量(LSM)(Spearman 相关系数 0.70,p<0.001)之间 FT 和 FS 之间存在很强的相关性。然而,FT 在较低的衰减参数和 LSM 时产生较高的值,而在较高的衰减参数和 LSM 时产生较低的值。使用 15kPa 的 LSM 截断值时具有实质性一致性,但使用 10kPa 和 20kPa 的 LSM 截断值和 248dB/m、268dB/m 和 280dB/m 的衰减参数截断值时仅具有中度一致性。与 FS 相比,FT 的衰减参数的 IQR 和 LSM 的 IQR/中位数显著较低(4dB/m 与 27dB/m,p<0.001,和 10 与 12,p<0.001,分别)。使用 FT 和 FS 的衰减参数和 LSM 的观察者内和观察者间可靠性均为良好至极好,组内相关系数为 0.89-0.99。FT 的检查时间更短(33s 与 47s,p<0.001),无效测量更少(0 与 2,p<0.001)。

结论

FT 和 FS 获得的测量值高度相关,但观察到它们的绝对值、一致性、检查时间和无效测量数量存在显著差异。经过充分培训,任何设备都可以由不同背景的医护人员使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a597/8092664/a562bbf19731/pone.0250300.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a597/8092664/0f578cca1eb5/pone.0250300.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a597/8092664/0767ca2efec1/pone.0250300.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a597/8092664/41a91d4a9390/pone.0250300.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a597/8092664/a562bbf19731/pone.0250300.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a597/8092664/0f578cca1eb5/pone.0250300.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a597/8092664/0767ca2efec1/pone.0250300.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a597/8092664/41a91d4a9390/pone.0250300.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a597/8092664/a562bbf19731/pone.0250300.g004.jpg

相似文献

1
Attenuation parameter and liver stiffness measurement using FibroTouch vs Fibroscan in patients with chronic liver disease.应用 FibroTouch 与 Fibroscan 检测慢性肝病患者的衰减参数与肝硬度值。
PLoS One. 2021 May 3;16(5):e0250300. doi: 10.1371/journal.pone.0250300. eCollection 2021.
2
[Correlation of liver stiffness measured by FibroTouch and FibroScan with Ishak fibrosis score in patients with chronic hepatitis B].[FibroTouch和FibroScan测量的肝脏硬度与慢性乙型肝炎患者Ishak纤维化评分的相关性]
Zhonghua Gan Zang Bing Za Zhi. 2017 Feb 20;25(2):145-150. doi: 10.3760/cma.j.issn.1007-3418.2017.02.013.
3
[Efficiency of FibroScan and FibroTouch in liver stiffness measurement and fat quantification: a comparative analysis].[FibroScan和FibroTouch在肝脏硬度测量和脂肪定量中的效率:一项比较分析]
Zhonghua Gan Zang Bing Za Zhi. 2016 Sep 20;24(9):652-658. doi: 10.3760/cma.j.issn.1007-3418.2016.09.004.
4
Feasibility and reliability of the FibroScan S2 (pediatric) probe compared with the M probe for liver stiffness measurement in small adults with chronic liver disease.FibroScan S2(儿科)探头与 M 探头在慢性肝病的小成人肝脏硬度测量中的可行性和可靠性比较。
Ann Hepatol. 2013 Jan-Feb;12(1):100-7.
5
[Correlation of FibroTouch and FibroScan with the stage of primary biliary cirrhosis].FibroTouch与FibroScan与原发性胆汁性肝硬化分期的相关性
Zhonghua Gan Zang Bing Za Zhi. 2016 Dec 20;24(12):902-906. doi: 10.3760/cma.j.issn.1007-3418.2016.12.005.
6
Non-invasive assessment of liver fibrosis with transient elastography (FibroScan®): applying the cut-offs of M probe to XL probe.瞬时弹性成像(FibroScan®)无创评估肝纤维化:应用 M 探头的截断值至 XL 探头。
Ann Hepatol. 2013 Jul-Aug;12(4):570-80.
7
Prospective Comparison of Transient Elastography Using Two Different Devices: Performance of FibroScan and FibroTouch.使用两种不同设备的瞬时弹性成像的前瞻性比较:FibroScan和FibroTouch的性能
Hepat Med. 2020 Mar 27;12:41-48. doi: 10.2147/HMER.S245455. eCollection 2020.
8
Feasibility study and reference values of FibroScan 502 with M probe in healthy preschool children aged 5 years.5 岁健康学龄前儿童 FibroScan 502 与 M 探头的可行性研究及参考值。
BMC Pediatr. 2019 Apr 24;19(1):129. doi: 10.1186/s12887-019-1487-6.
9
Accuracy of liver stiffness measurement and controlled attenuation parameter using FibroScan M/XL probes to diagnose liver fibrosis and steatosis in patients with nonalcoholic fatty liver disease: a multicenter prospective study.使用 FibroScan M/XL 探头测量肝脏硬度和受控衰减参数诊断非酒精性脂肪性肝病患者肝纤维化和脂肪变性的准确性:一项多中心前瞻性研究。
J Gastroenterol. 2020 Apr;55(4):428-440. doi: 10.1007/s00535-019-01635-0. Epub 2019 Oct 25.
10
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.肝纤维化无创诊断技术评估非酒精性脂肪性肝病患者肝脏脂肪变及纤维化的准确性。
Gastroenterology. 2019 May;156(6):1717-1730. doi: 10.1053/j.gastro.2019.01.042. Epub 2019 Jan 25.

引用本文的文献

1
Comparison of two transient elastography (TE) systems for measuring liver stiffness in clinical practice.两种瞬时弹性成像(TE)系统在临床实践中测量肝脏硬度的比较。
Sci Rep. 2025 Jul 1;15(1):22277. doi: 10.1038/s41598-025-06151-1.
2
Effect of 5:2 intermittent fasting diet versus daily calorie restriction eating on metabolic-associated fatty liver disease-a randomized controlled trial.5:2间歇性禁食饮食与每日热量限制饮食对代谢相关脂肪性肝病的影响——一项随机对照试验
Front Nutr. 2024 Aug 20;11:1439473. doi: 10.3389/fnut.2024.1439473. eCollection 2024.
3
Liver Stiffness and Steatosis Measurements with iLivTouch and FibroScan: A Comparative Study.

本文引用的文献

1
Normal liver stiffness and influencing factors in healthy children: An individual participant data meta-analysis.健康儿童的正常肝脏硬度及影响因素:一项个体参与者数据的荟萃分析。
Liver Int. 2020 Nov;40(11):2602-2611. doi: 10.1111/liv.14658.
2
Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.《2019年丙型肝炎指南更新:美国肝病研究协会-美国传染病学会关于丙型肝炎病毒感染检测、管理及治疗的建议》
Hepatology. 2020 Feb;71(2):686-721. doi: 10.1002/hep.31060.
3
Comparing point shear wave elastography (ElastPQ) and transient elastography for diagnosis of fibrosis stage in non-alcoholic fatty liver disease.
iLivTouch 和 FibroScan 检测肝脏硬度和脂肪变:一项对比研究。
Turk J Gastroenterol. 2024 Jun 6;35(8):634-642. doi: 10.5152/tjg.2024.23531.
4
Palm-Sized Wireless Transient Elastography System with Real-Time B-Mode Ultrasound Imaging Guidance: Toward Point-of-Care Liver Fibrosis Assessment.具有实时B模式超声成像引导的手掌大小的无线瞬态弹性成像系统:用于即时护理肝脏纤维化评估
Diagnostics (Basel). 2024 Jan 15;14(2):0. doi: 10.3390/diagnostics14020189.
5
Prevalence of metabolic syndrome and metabolic dysfunction-associated fatty liver disease in Malaysia 2023: study protocol for a community-based nationwide cross-sectional survey.2023 年马来西亚代谢综合征和代谢相关脂肪性肝病的流行情况:一项基于社区的全国性横断面调查研究方案。
BMJ Open. 2023 Oct 27;13(10):e074432. doi: 10.1136/bmjopen-2023-074432.
6
Non-invasive assessment of metabolic dysfunction-associated fatty liver disease.代谢功能障碍相关脂肪性肝病的非侵入性评估
Ther Adv Endocrinol Metab. 2022 Dec 10;13:20420188221139614. doi: 10.1177/20420188221139614. eCollection 2022.
7
Vibration-controlled Transient Elastography in NAFLD: Review Study.非酒精性脂肪性肝病中的振动控制瞬时弹性成像:综述研究
Euroasian J Hepatogastroenterol. 2022 Jul;12(Suppl 1):S41-S45. doi: 10.5005/jp-journals-10018-1365.
8
Ultrasound Methods for the Assessment of Liver Steatosis: A Critical Appraisal.评估肝脏脂肪变性的超声方法:批判性评价
Diagnostics (Basel). 2022 Sep 22;12(10):2287. doi: 10.3390/diagnostics12102287.
9
Effect of a High Protein, Low Glycemic Index Dietary Intervention on Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized Controlled Trial.高蛋白、低血糖指数饮食干预对代谢功能障碍相关脂肪性肝病的影响:一项随机对照试验。
Front Nutr. 2022 Apr 27;9:863834. doi: 10.3389/fnut.2022.863834. eCollection 2022.
比较点剪切波弹性成像(ElastPQ)和瞬时弹性成像在非酒精性脂肪性肝病纤维化分期诊断中的应用。
J Gastroenterol Hepatol. 2020 Jan;35(1):135-141. doi: 10.1111/jgh.14782. Epub 2019 Jul 29.
4
Comparison of FibroTouch and FibroScan for staging fibrosis in chronic liver disease: Single-center prospective study.FibroTouch 与 FibroScan 用于慢性肝病纤维化分期的比较:单中心前瞻性研究。
Dig Liver Dis. 2019 Sep;51(9):1323-1329. doi: 10.1016/j.dld.2019.02.009. Epub 2019 Feb 28.
5
Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中 M 和 XL 探头测量肝脏硬度的统一解读。
Gut. 2019 Nov;68(11):2057-2064. doi: 10.1136/gutjnl-2018-317334. Epub 2019 Jan 18.
6
Can the same controlled attenuation parameter cut-offs be used for M and XL probes for diagnosing hepatic steatosis?用于诊断肝脂肪变性的 M 及 XL 探头,能否使用相同的受控衰减参数截断值?
J Gastroenterol Hepatol. 2018 Oct;33(10):1787-1794. doi: 10.1111/jgh.14150. Epub 2018 May 7.
7
Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment.2017年亚太地区非酒精性脂肪性肝病工作小组指南 - 第1部分:定义、危险因素及评估
J Gastroenterol Hepatol. 2018 Jan;33(1):70-85. doi: 10.1111/jgh.13857.
8
American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases.美国胃肠病学会协会弹性成像技术在慢性肝病中的作用技术评论。
Gastroenterology. 2017 May;152(6):1544-1577. doi: 10.1053/j.gastro.2017.03.016.
9
Controlled attenuation parameter using the FibroScan® XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population.使用FibroScan® XL探头的受控衰减参数对亚洲人群非酒精性脂肪性肝病的肝脂肪变性进行定量分析。
United European Gastroenterol J. 2017 Feb;5(1):76-85. doi: 10.1177/2050640616646528. Epub 2016 Jun 23.
10
[Correlation of liver stiffness measured by FibroTouch and FibroScan with Ishak fibrosis score in patients with chronic hepatitis B].[FibroTouch和FibroScan测量的肝脏硬度与慢性乙型肝炎患者Ishak纤维化评分的相关性]
Zhonghua Gan Zang Bing Za Zhi. 2017 Feb 20;25(2):145-150. doi: 10.3760/cma.j.issn.1007-3418.2017.02.013.